title: DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
authors.affiliation: Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
authors.forename: Minjun
authors.initials: M
authors.lastname: Chen
authors.affiliation: Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
authors.forename: Ayako
authors.initials: A
authors.lastname: Suzuki
authors.affiliation: Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
authors.forename: Shraddha
authors.initials: S
authors.lastname: Thakkar
authors.affiliation: Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
authors.forename: Ke
authors.initials: K
authors.lastname: Yu
authors.affiliation: Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA.
authors.forename: Chuchu
authors.initials: C
authors.lastname: Hu
authors.affiliation: Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA. Electronic address: weida.tong@fda.hhs.gov.
authors.forename: Weida
authors.initials: W
authors.lastname: Tong
mesh_terms: D056486:Chemical and Drug Induced Liver Injury; D016208:Databases, Factual; D004348:Drug Labeling; D006801:Humans; D004364:Pharmaceutical Preparations / Q000145:classification*; D012306:Risk
chemical_list: D004364:Pharmaceutical Preparations